ArticleMikrochimica acta2026
Integration of cefradine-modified dextran-coated magnetite nanoparticles and IgG-modified time-resolved fluorescent microsphere with improved performance for ultrasensitive detection of Staphylococcus aureus in clinical samples.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
An improved strategy based on dual-specificity recognition synergy for ultrasensitive detection of viable Staphylococcus aureus (S. aureus) in clinical samples is proposed. A hydrophilic cefradine-modified dextran-coated magnetic nanoparticle (CDMN) was fabricated as a recognition unit for selective capture of target S. aureus. Meanwhile, a hydrophilic IgG-modified time-resolved fluorescent microsphere (ITFM) was prepared as a labeling unit for specific labeling of target S. aureus by the specific interaction between the Fc region of IgG and protein A on the surface of S. aureus. To prove the practicability, the CDMN-linked ITFM (CDMN-ITFM) strategy was constructed for the determination of S. aureus. In short, CDMN selectively captured S. aureus from complex samples containing numerous interfering molecules, and then ITFM specifically labeled S. aureus captured by CDMN; subsequently, the CDMN-bacteria-ITFM complex was isolated and washed, followed by elution to release ITFM; finally, the fluorescence signal of ITFM in the suspension was quantitatively analyzed. Intriguingly, due to the presence of numerous hydrophilic groups in CDMN and ITFM, non-specific adsorption was effectively limited during the capture and labeling of S. aureus, which further reduced background fluorescence signals and improved sensitivity. Therefore, the limit of detection (LOD) of the improved CDMN-ITFM strategy was 8 CFU mL
Indexed as
Identifiers
42581248What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.